Uncertainty around tariffs is a disincentive for pharma onshoring in the US
Pharmaceutical Technology
AUGUST 11, 2025
Request a free demo for GlobalData’s Strategic Intelligence here. Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
Let's personalize your content